Shield Blood Test for Colon Cancer Screening

If you want a Shield blood test, start by asking a provider whether it fits your colorectal screening needs. Send your age, last screening test and result, and personal and family history. Confirm whether an order and blood collection can be arranged before planning the draw. The screening limits and alternatives below remain part of that decision.

Care starts by chat with a licensed provider. Message us and we will confirm coverage in your state.

1 Big Thing

Shield is a prescription blood test for colorectal cancer screening in adults age 45 and older at average risk. It offers a way to screen without collecting stool or preparing for a colonoscopy. A positive result still needs a colonoscopy, and a negative result does not rule out cancer. [1]

The more useful question is where it belongs in your screening plan. The American Cancer Society's 2026 guideline recommends blood testing only for people who decline or do not complete preferred screening options. Those preferred options include stool tests and visual exams. [3]

Why It Matters

If a colonoscopy referral has sat unfinished or a stool kit keeps getting put aside, another option can make the conversation easier. But convenience and cancer prevention are different benefits. Shield has limited ability to find precancerous growths, which is a central reason to discuss the alternatives before choosing it. [2,3]

You do not have to decide from an advertisement. Start with the reason you have not screened, the tests you could realistically complete, and what you would do if the result were positive. That gives your clinician something concrete to work with.

Between the Lines

Shield looks for changes in fragments of DNA circulating in the blood that can be associated with colorectal cancer. The laboratory analyzes the sample and reports a positive or negative result to the ordering clinician. It does not look inside the colon, take a biopsy, or remove a polyp. [1,2]

That distinction explains why the phrase "a blood test instead of a colonoscopy" can be misleading. For an eligible person choosing a screening test, Shield may be the initial test. Once a result is positive, or when a colonoscopy is needed to investigate symptoms or provide surveillance, the blood test is not a substitute. [1,2]

A useful way to discuss the choice is to separate the first appointment from the complete plan. The first appointment might only involve blood collection. The complete plan also includes receiving the result, arranging any necessary follow-up, and deciding how future screening will happen.

Go Deeper

The FDA's approval study summary reports that Shield detected about 83% of colorectal cancers. That is a cancer-detection figure, not a promise to find 83% of polyps or prevent 83% of future cancers. [1]

The product labeling warns that detection of stage I cancer was only 55%-65% and that the test missed approximately 87% of precancerous lesions. These limits matter even when a test is easier to complete. Finding an existing cancer and finding a growth before it becomes cancer are not interchangeable outcomes. [2]

Our separate guide to Shield accuracy and false results explains the denominators behind the headline numbers. The screening comparison focuses on the practical choices.

What happens at the blood draw?

The FDA describes collection of up to four tubes using the Shield collection kit, followed by testing at Guardant Health's laboratory. Special preparation is not required. Guardant's patient FAQ also says fasting is not needed and describes collection at a clinician's office or a nearby laboratory. [1,4]

Ask the ordering office where the draw will happen and whether you need to bring anything. If other laboratory tests are being collected at the same visit, check their instructions separately. Do not assume that every test on a shared order has the same preparation requirements.

Guardant estimates results in approximately two weeks. Treat that as the manufacturer's estimate, not a guaranteed delivery date. Before leaving, find out who will contact you and how to follow up if no result arrives. [4]

Who should pause before choosing Shield?

The test is intended for average-risk screening. A personal history of colorectal cancer or adenomas, a first-degree relative with colorectal cancer, inflammatory bowel disease, and certain hereditary syndromes are among the exclusions in the labeling. Share your previous screening reports and family history before an order is placed. [2]

Blood in the stool, a persistent change in bowel habits, unexplained weight loss, abdominal discomfort that does not go away, or iron-deficiency anemia deserve a clinical assessment. These symptoms can have causes other than cancer, but a screening test should not become the reason to postpone finding out what is causing them. [5]

Does FDA approval mean it is the preferred test?

No. Approval establishes an authorized use for a particular product. A guideline compares the place of different options in a screening program. Shield received FDA approval on July 26, 2024; the ACS's later guideline still places blood testing after preferred options that a person declines or does not complete. [1,3]

Those positions can both be true. An available test may be useful for a specific person without being the first choice for everyone. Ask which reason applies to you, rather than assuming that newer technology automatically changes your existing plan.

Closing

If you want to discuss screening with Well Revolution, start with a message. Include your age, the date and result of your last screening test, any personal or family history of colorectal cancer or polyps, and whether you have symptoms. Ask which screening approach fits and what follow-up would involve.

Before arranging a Shield draw, review the eligibility guide and cost and insurance checklist. Guardant also provides a patient starting page to discuss with your clinician. An online questionnaire is a starting point for that conversation. [6] Our step-by-step guide to getting the Shield test online in the US covers the order, the blood draw and what happens next.

What it costs with Well Revolution

$50 for a prescription. If approved, you will receive a prescription for the Shield lab order and 30 days of support. Guardant runs the test and reports the result. We are there for those 30 days to interpret it, arrange referrals, and treat if needed. Perfect for a single screening test.

Or $90 for the Unlimited Membership. If approved, you will receive 3 months of care with 7 days a week support, plus unlimited prescriptions, lab tests, imaging orders, letters and referrals with same day care, cancel anytime, no fees. Perfect for established patients looking for full care.

Getting started with Well Revolution

Care is chat-based with a licensed provider, same day, no appointment needed. Message us with your age, your last screening test and its result, and your personal and family history, tell us where you are, and we will confirm coverage in your state and which screening approach fits before you commit to anything.

References

• [1] FDA. Shield: approval overview. 2024.
• [2] Guardant Health / FDA. Shield instructions for use and provider labeling, P230009C. 2024.
• [3] Wolf AMD et al. Colorectal cancer screening: An update to the American Cancer Society guideline, 2026. 2026.
• [4] Guardant Health. Completing the Shield test. accessed 2026-09-06.
• [5] CDC. Symptoms of Colorectal Cancer. 2026.
• [6] Guardant Health. How to Get Started with Shield for Colon Cancer Screening. accessed 2026-09-06.

Reviewed by PA Michael Rubio, US Medical Director